Home › Therapeutic areas › Metabolic › Gaucher Disease
Gaucher Disease (2 companies)
Companies with an active program in Gaucher Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics | MetabolicNeurology Rare | 1 | Phase 1 | $45.0M | 5 |
| VYGR | Voyager Therapeutics | MetabolicNeurology Rare | 1 | Phase 1 | $116M | 9 |
No companies match.